Reducing length of stay with the direct oral anti-coagulants in low and intermediate risk pulmonary embolism: a single center experience
J Filopei, EE Bondarsky, M Ehrlich, M Islam… - Journal of Thrombosis …, 2020 - Springer
Direct oral anti-coagulants (DOACs) reduce hospital length-of-stay (LOS) in patients with
acute pulmonary embolism (PE) in clinical trials. There is a paucity of literature describing …
acute pulmonary embolism (PE) in clinical trials. There is a paucity of literature describing …
Reducing length of stay with the direct oral anti-coagulants in low and intermediate risk pulmonary embolism: a single center experience.
J Filopei, EE Bondarsky, M Ehrlich, M Islam… - … of Thrombosis and …, 2020 - europepmc.org
Direct oral anti-coagulants (DOACs) reduce hospital length-of-stay (LOS) in patients with
acute pulmonary embolism (PE) in clinical trials. There is a paucity of literature describing …
acute pulmonary embolism (PE) in clinical trials. There is a paucity of literature describing …
Reducing length of stay with the direct oral anti-coagulants in low and intermediate risk pulmonary embolism: a single center experience
F Jason, EE Bondarsky, M Ehrlich… - … of Thrombosis and …, 2020 - search.proquest.com
Direct oral anti-coagulants (DOACs) reduce hospital length-of-stay (LOS) in patients with
acute pulmonary embolism (PE) in clinical trials. There is a paucity of literature describing …
acute pulmonary embolism (PE) in clinical trials. There is a paucity of literature describing …
Reducing length of stay with the direct oral anti-coagulants in low and intermediate risk pulmonary embolism: a single center experience
J Filopei, EE Bondarsky, M Ehrlich… - … of Thrombosis and …, 2020 - einstein.elsevierpure.com
Direct oral anti-coagulants (DOACs) reduce hospital length-of-stay (LOS) in patients with
acute pulmonary embolism (PE) in clinical trials. There is a paucity of literature describing …
acute pulmonary embolism (PE) in clinical trials. There is a paucity of literature describing …
Reducing length of stay with the direct oral anti-coagulants in low and intermediate risk pulmonary embolism: a single center experience
J Filopei, EE Bondarsky, M Ehrlich… - … of thrombosis and …, 2020 - pubmed.ncbi.nlm.nih.gov
Direct oral anti-coagulants (DOACs) reduce hospital length-of-stay (LOS) in patients with
acute pulmonary embolism (PE) in clinical trials. There is a paucity of literature describing …
acute pulmonary embolism (PE) in clinical trials. There is a paucity of literature describing …